Popp Erik, Vogel Peter, Teschendorf Peter, Böttiger Bernd W
Department of Anaesthesiology, University of Heidelberg, Im Neuenheimer Feld 110, D-69120 Heidelberg, Germany.
Resuscitation. 2007 Aug;74(2):344-51. doi: 10.1016/j.resuscitation.2007.01.019. Epub 2007 Mar 26.
After transient global cerebral ischaemia, selectively vulnerable areas of the brain show delayed neuronal degeneration. Recent data have demonstrated potent neuroprotective effects of the application of growth hormones like erythropoietin (EPO) after focal cerebral ischaemia. In order to assess possible effects of the application of EPO on cerebral recovery after cardiac arrest in rats, the vulnerable hippocampal CA-1 sector was investigated.
Thirty male Wistar rats were randomised into two groups (EPO versus placebo; n=15 per group). Cardiac arrest was induced by ventricular fibrillation during general anaesthesia. After 6 min of global cerebral ischaemia, animals were resuscitated by external chest compressions combined with defibrillation. Investigator blinded bolus application of EPO (5000 IE/kg bodyweight) and placebo was performed at three different time points, respectively: 5 min before cardiac arrest (i.v.; intravenously), 24h (i.p.; intraperitoneally) and 72 h (i.p.) after ischaemia. At 24h, 72 h and 7 days, animals were tested according to a neurological deficit score. After of reperfusion, coronal brain sections were analysed by TUNEL- and Nissl-staining. A caspase activity assay was done to determine antiapoptotic properties of EPO. Statistical analyses were done using ANOVA.
Neurological deficit scoring did not show differences between the groups. However, in all groups typical delayed neuronal degeneration could be found in the CA-1 sector. There was no difference in neuronal survival between the groups (viable neurons EPO (median [interquartile range]): 15.5 [10.1-21.3]; placebo: 16.8 [7.7-26.3]). Results from TUNEL-staining revealed no differences in the amount of apoptotic cell death between the groups (EPO: 71.2 [58.1-81.8]; placebo: 73.4 [67.8-78.2]). Caspase activity assays demonstrated a strong expression of general caspase activity as well as caspase-3 activity in the CA-1 sector and the nucleus reticularis thalami, without any differences between both groups.
Despite the well known neuroprotective properties of EPO in ischaemia induced neuronal degeneration, this study could not reveal any beneficial effects of EPO after global cerebral ischaemia due to cardiac arrest in rats.
短暂性全脑缺血后,大脑的选择性易损区域会出现延迟性神经元变性。最近的数据表明,局灶性脑缺血后应用促红细胞生成素(EPO)等生长激素具有强大的神经保护作用。为了评估EPO对大鼠心脏骤停后脑恢复的可能影响,对易损的海马CA-1区进行了研究。
30只雄性Wistar大鼠随机分为两组(EPO组与安慰剂组;每组n = 15)。在全身麻醉期间通过心室颤动诱导心脏骤停。全脑缺血6分钟后,通过外部胸外按压联合除颤对动物进行复苏。研究人员分别在三个不同时间点进行盲法推注EPO(5000 IE/kg体重)和安慰剂:心脏骤停前5分钟(静脉内)、缺血后24小时(腹腔内)和72小时(腹腔内)。在24小时、72小时和7天时,根据神经功能缺损评分对动物进行测试。再灌注后,通过TUNEL和尼氏染色分析冠状脑切片。进行半胱天冬酶活性测定以确定EPO的抗凋亡特性。使用方差分析进行统计分析。
两组之间神经功能缺损评分没有差异。然而,在所有组中,CA-1区均发现典型的延迟性神经元变性。两组之间的神经元存活率没有差异(存活神经元EPO(中位数[四分位间距]):15.5 [10.1 - 21.3];安慰剂:16.8 [7.7 - 26.3])。TUNEL染色结果显示两组之间凋亡细胞死亡数量没有差异(EPO:71.2 [58.1 - 81.8];安慰剂:73.4 [67.8 - 78.2])。半胱天冬酶活性测定表明CA-1区和丘脑网状核中普遍的半胱天冬酶活性以及半胱天冬酶-3活性均有强烈表达,两组之间没有任何差异。
尽管EPO在缺血诱导的神经元变性中具有众所周知的神经保护特性,但本研究未能揭示EPO对大鼠心脏骤停所致全脑缺血后的任何有益作用。